Fig. 1
From: Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
General profiles in control rats and TAA-induced fibrotic rats with or without osthole treatment. a Rat liver images from three groups: control rats were given only CMC (n = 8); and TAA-group rats were given CMC with TAA injection (n = 10); TAA + osthole-group rats were gavage osthole (10 mg/kg) in CMC with TAA injection (n = 10). The protocol of treatment was described in the Methods. Scale bar represents 1 cm for livers. b Plasma levels of ALT and AST from all groups. c Liver weight was recorded after sacrifice. Data are shown as mean ± SD of 8 rats in each group.*p < 0.05; **p < 0.01, compared with other groups